aTyr Pharma Inc (NASDAQ:LIFE): Andreas Halvorsen’s Viking Global filed an amended 13D.
You can check out Viking Global’s latest holdings and filings here.
Please follow Viking Global (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Viking Global or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Viking Global Investors||0||2,932,229||0||2,932,229||2,932,229||9.5%|
|Viking Global Opportunities GP||0||2,932,229||0||2,932,229||2,932,229||9.5%|
|Viking Global Opportunities Portfolio GP||0||2,932,229||0||2,932,229||2,932,229||9.5%|
|Viking Global Opportunities Illiquid Investments Sub-Master||0||2,932,229||0||2,932,229||2,932,229||9.5%|
|O. Andreas Halvorsen||0||2,932,229||0||2,932,229||2,932,229||9.5%|
|David C. Ott||0||2,932,229||0||2,932,229||2,932,229||9.5%|
|Rose S. Shabet||0||2,932,229||0||2,932,229||2,932,229||9.5%|
Page 1 of 14 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b),(c)
AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934*
aTyr Pharma, Inc.
(Name of Issuer)
Common stock, par value $0.001 per share
(Title of Class of Securities)
August 31, 2017
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).